Pms-irbesartan: Affected Lot May Contain Pms-irbesartan/hctz 150/12.5 Mg Tablets.
Recall Summary pms-IRBESARTAN 150 mg tablets distributed across Canada may be contaminated. The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets instead of the labeled pms-IRBESARTAN 150 mg. This is a Class II recall affecting patients who use this medication.
- Product
- pms-IRBESARTAN 150 mg Tablet
- Reason
- Contamination
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-08-12
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/3ce10a68-7290-4e23-871a-92b0153b8f99